AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) saw strong trading volume on Wednesday . 1,774,458 shares changed hands during mid-day trading, an increase of 43% from the previous session’s volume of 1,239,007 shares.The stock last traded at $5.23 and had previously closed at $5.00. Analysts Set New Price Targets A number of research firms […]
AbCellera Biologics (NASDAQ:ABCL) Cut to Hold at Benchmark themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Shares of AbCellera Biologics Inc. (NASDAQ:ABCL – Get Free Report) have been assigned an average recommendation of “Buy” from the seven research firms that are currently covering the stock, Marketbeat Ratings reports. Seven investment analysts have rated the stock with a buy recommendation. The average 12-month price target among analysts that have issued ratings on […]
AbCellera Biologics (NASDAQ:ABCL – Get Free Report) announced its quarterly earnings results on Thursday. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.13) by $0.02, Briefing.com reports. The business had revenue of $10.10 million for the quarter, compared to analyst estimates of $12.38 million. AbCellera Biologics had a negative return […]
AbCellera Biologics Inc. (NASDAQ:ABCL – Get Rating) has been assigned an average rating of “Buy” from the eight research firms that are covering the company, MarketBeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price target among analysts that have issued ratings on the stock in the […]